auroramj.com (ACB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

The EV/EBITDA valuation chart for Aurora Cannabis (ACB) is 0.00. Aurora Cannabis (ACB) relies on the premium medical segment in the EU and Canada, creating barriers for low-cost alternatives. The company attracts highly specialized experts through a stock option system. Supply security is guaranteed by strict government control and the use of specialized transport with total cargo monitoring.

Aurora - ACB EV/EBITDA Multiple (period 11/23/2025 - 11/14/2026)

Comprehensive metric breakdowns and analytics for auroramj.com (ACB)

- market price and analyst price targets:

Price Chart Aurora Cannabis Inc.|ACB - Fair Value Consensus

- market capitalization indicators:

Market Value Aurora Cannabis Inc.|ACB - Real Price to Acquire Entire Company

- book value of equity indicators:

Book Value per Share Aurora Cannabis|ACB - Book Capitalization|Market Cap to Net Assets Ratio auroramj.com|ACB - Company Total Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

ACB - Final Profit|Projected Future Earnings Aurora Cannabis|ACB - Price to Earnings Ratio|Forward P/E Multiple Aurora Cannabis Inc.|ACB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aurora Cannabis Inc.|ACB - Operating profit before amortization|Earnings per share for the last twelve months Aurora Cannabis|ACB - Earnings per share for the last 12 months|Quarterly EPS earnings growth auroramj.com|ACB - Earnings growth in current year|Earnings growth forecast for next year Aurora Cannabis

- total revenue and sales volume data:

ACB - Company Revenue|Projected Sales Volume Aurora Cannabis Inc.|ACB - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Aurora Cannabis Inc.

Initial company analysis:ACB (Aurora)

Original product of Aurora Cannabis Inc.

This indicator determines the strategic capital planning horizon for capital-intensive enterprises with high debt loads. The metric compares the total enterprise value, including debt, with earnings before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA multiple over time, an investor can promptly identify asset overvaluation. Workforce stabilization and the retention of key technologists at Aurora Cannabis (ACB) create a foundation for optimizing this metric through increased efficiency.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indivior Group INDV|Business Value to Operating Income Before Depreciation COLL|CRON - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|canopygrowth.com (CGC) - Enterprise Value to EBITDA Ratio|HITI: EV/EBITDA Multiple|Achieve Life Sciences Inc. (ACHV) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio SKYE|EV/EBITDA Multiple Anebulo Pharma|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InterCure Ltd. (INCR)|NTRB (nutriband.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nasus Pharma NSRX|India Globalization Capital (IGC) - Company Value to EBITDA|MIRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation FLGC (Flora Growth Inc)|IMCC: EV/EBITDA Multiple|Adial Pharmaceuticals, Inc. (ADIL) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ARTL|ENSC: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple TTNP|Enterprise Value to EBITDA Ratio Greenlane Corp GNLN|EV/EBITDA Multiple INM (InMed Pharmaceuticals)|EV/EBITDA Multiple akandacorp.com AKAN|ENVB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BGXX (Bright Green) - Enterprise Value to Operating Income Before Depreciation|Hempacco (HPCO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization